Enhanced indexing solutions for insurers

Enhanced indexing solutions for insurers

26-03-2020 | Insight
Over the past decade, investors have operated a massive shift from actively managed strategies into passive ones. For insurance companies, the move towards passive has often been encouraged through their strategic asset allocation processes typically using common equity indices as a benchmark.
  • Edward Collinge
    Global Head of Insurance Strategy
  • Jan de Koning
    de Koning
    Portfolio Manager

Speed read

  • Passive products based on public indices present serious drawbacks
  • Many insurers move to ‘middle-ground’ between passive and active
  • We explain the benefits of targeting time-tested factor premiums
Solutions for insurers

For insurers to make the most of a strategy, customization is essential.

Read more

Going passive for their equity allocation has therefore been a natural step, as they sought more cost-effective solutions for their investments. But while passive products based on public indices have their merits, they also present serious drawbacks. This is encouraging a growing number of insurers to move to ‘middle-ground’ between passive and traditional active products, in particular Enhanced Indexing solutions that target time-test factor premiums with a low and controlled tracking error.

In this paper, we explain the benefits of targeting time-tested factor premiums for insurers. We also discuss why enhanced indexing is increasingly becoming a cornerstone of many insurers’ developed and emerging market portfolios.

Leave your details and download the publication


This report is not available for users from countries where the offering of foreign financial services is not permitted, such as US Persons.

Your details are not shared with third parties. This information is exclusively intended for professional investors. All requests are checked.



The information contained in the website is solely intended for professional investors. Some funds shown on this website fall outside the scope of the Dutch Act on the Financial Supervision (Wet op het financieel toezicht) and therefore do not (need to) have a license from the Authority for the Financial Markets (AFM).

The funds shown on this website may not be available in your country. Please select your country website (top right corner) to view the products that are available in your country.

Neither information nor any opinion expressed on the website constitutes a solicitation, an offer or a recommendation to buy, sell or dispose of any investment, to engage in any other transaction or to provide any investment advice or service. An investment in a Robeco product should only be made after reading the related legal documents such as management regulations, prospectuses, annual and semi-annual reports, which can be all be obtained free of charge at this website and at the Robeco offices in each country where Robeco has a presence.

By clicking Proceed I confirm that I am a professional investor and that I have read, understood and accept the terms of use for this website.